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Adherence to biopsy guidelines increases celiac disease diagnosis
Benjamin Lebwohl, MD, MS, Robert C. Kapel, MD, Alfred I. Neugut, MD, PhD, Peter H.R. Green, MD,
Robert M. Genta, MD
New York, New York; Danbury, Connecticut; Irving, Texas; Dallas, Texas, USA
Background: Celiac disease (CD) is common but underdiagnosed in the United States. A proposed quality
guideline recommends that4 specimens be submitted during duodenal biopsy. The degree of adherence to this
recommendation in clinical practice is unknown.
Objective: To measure the number of specimens submitted during duodenal biopsy among patients throughout
the United States and to determine the incremental diagnostic yield of adherence to the recommended number
of specimens.
Design: Retrospective cohort study.
Patients: This study involved 132,352 patients without known CD who underwent duodenal biopsy.
Intervention: Duodenal biopsy.
Main Outcome Measurements: Duodenal biopsy specimens were submitted to a pathology laboratory
operating in 43 states in the United States. We used multivariate logistic regression to identify factors associated
with submitting 4 specimens. We also compared the prevalence of newly diagnosed CD in biopsies with 4
specimens with that in biopsies with 4 specimens.
Results:Of the 132,352 patients who underwent biopsy (67% women, mean age 52.9 years),4 specimens were
submitted in 45,995 cases (35%). A modest increase in the proportion of biopsies with 4 specimens occurred
after this guideline was proposed in 2006 (odds ratio for 2009 vs 2006, 1.51; 95% confidence interval, 1.22-1.88),
but the rate of adherence in 2009 remained low at 37%. Among patients in whom the indication was
malabsorption/suspected CD (n  3261), adherence to this standard was only 39.5%. The probability of a new
diagnosis of CD was increased when 4 specimens were submitted (1.8% vs 0.7%; P  .0001).
Limitations: Retrospective analysis lacking clinical follow-up. The guideline publication occurred during the
study period, possibly influencing clinical practice and confounding results.
Conclusion: Although this proposed standard remains a subject of debate, adherence to submitting 4 specimens
is low in the United States. Adherence yields a diagnosis rate of 1.8%, a small absolute increase but a doubling of the
diagnosis rate of CD. Efforts to increase adherence are warranted. (Gastrointest Endosc 2011;74:103-9.)S
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ICeliac disease (CD) is an autoimmune disease that is
triggered by the ingestion of gluten in genetically predis-
posed individuals.1 The prevalence of CD in the United
Abbreviation: CD, celiac disease.
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Adherence to guidelines and celiac disease diagnosis Lebwohl et alreduced after diagnosis and treatment with a gluten-free
diet.4-11
Deficiencies in quality related to endoscopic evaluation
may contribute to the low rates of diagnosis of CD in the
United States. A multicenter endoscopy database study
found that the majority of patients undergoing upper GI
endoscopy for such indications as anemia, iron deficiency,
and weight loss did not have a duodenal biopsy done
during the procedure.12
Because the histopathologic features of CD are patchy,
guidelines recommend that 4 to 6 biopsy specimens of the
small bowel be submitted during upper endoscopy when
CD is under consideration.1,13 These proposed quality
guidelines have been borne out by studies of patients with
known CD, in which the sensitivity of duodenal biopsy
was shown to decline when fewer than 4 specimens were
examined.14-15 The degree to which endoscopists adhere
o such recommendations in clinical practice and the di-
gnostic yield of adherence to this standard have not been
tudied.
By using a large, national, pathology database spanning
he first 4 years during which these recommendations
ppeared (2006-2009), we assessed adherence to these
roposed guidelines. To determine the diagnostic yield of
he recommendation to submit 4 specimens, we inves-
igated the association between adherence to this standard
nd the proportion of patients with the finding of a new
iagnosis of CD. We also aimed to identify patient and
rocedure-related factors associated with the submission
f 4 specimens. In so doing, this study elucidates how a
uideline plays out in clinical practice, both in terms of
dherence to the recommendation as well as the incre-
ental yield of adherence.
METHODS
Study setting
The GI pathology division of Caris Life Sciences (Irving,
Texas) is a specialized pathology laboratory that receives
specimens from outpatient GI endoscopy centers in 43
states throughout the United States as well as the District of
Columbia and Puerto Rico. Caris Life Sciences maintains a
database of all patients who had endoscopic procedures in
which a specimen was submitted to the laboratory. Pa-
tients and providers were de-identified in the preparation
of the database for this analysis. For each specimen, the
following is available: sex and age of the patient; proce-
dure year, location, and provider; summary of the clinical
history; endoscopic impressions; and histopathologic find-
ings. For a subset of procedures, more detailed informa-
tion on the indication for the examination and endoscopic
findings are exported from the endoscopy report and are
retrievable via free-text search. p
104 GASTROINTESTINAL ENDOSCOPY Volume 74, No. 1 : 2011istopathologic criteria
In this laboratory, biopsies are interpreted by a group of
I pathologists who share a common approach to biopsy
valuation and use a predetermined approach to speci-
en handling, diagnostic criteria, and terminology.
Pathologic abnormalities of the duodenum in this lab-
ratory are grouped in accordance with the classification
eveloped by Marsh16 and Oberhuber et al.17 As in a
revious analysis of yield of duodenal biopsy according to
ndication by using a subset of this data,18 the following
lassification of outcomes was used: normal duodenal
ucosa; duodenal intraepithelial lymphocytosis, as de-
ned as 25 intraepithelial lymphocytes per 100 entero-
ytes, with or without crypt hypertrophy (equivalent to
arsh I or II lesions); blunted villi (Marsh IIIA); or flat villi
Marsh IIIB/C). Other recorded pathologic abnormalities
nclude gastric metaplasia of the duodenal mucosa, re-
ardless of the presence of Helicobacter pylori (“peptic
uodenopathy” or “peptic duodenitis”),19 and mild intra-
pithelial lymphocytosis (as indicated by the presence of
ntraepithelial lymphocytes not meeting the threshold for
arsh I).
ase identification
We queried the database for all small-intestine speci-
ens retrieved during upper endoscopy on individuals
ged 18 years during the 4-year period from January 1,
006 to December 31, 2009. This query included any
pecimen labeled with the term duodenum, duodenal,
mall bowel, or small intestine and excluded any specimen
hat contained the word aspirate or aspiration so as to
xclude fluid analysis from the dataset.
For individuals who underwent more than one exami-
ation during this period, we included only the first chro-
ological examination. Because the primary aim was to
ssess biopsy practices in patients without known CD, we
xcluded any patient with a known history of CD as
escribed in the clinical indication field. To determine the
umber of duodenal biopsy specimens for each biopsy
et, we used a free-text search of the pathologist’s descrip-
ion of each sample. When present, specimens from the
uodenal bulb (identified either in the endoscopist’s re-
Take-homeMessage
● Adherence to the proposed standard of submitting4
specimens occurred in only 35% of all endoscopies with
duodenal biopsy. Adherence was less than 40%, even for
those examinations in which the indication for
endoscopy was malabsorption or suspected celiac
disease.
● The probability of a new diagnosis of celiac disease more
than doubled when4 specimens were submitted.ort or the histopathologic interpretation) were included
www.giejournal.org
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Lebwohl et al Adherence to guidelines and celiac disease diagnosisin the total number of specimens submitted. Cases in
which the number of specimens submitted was not quan-
tified (either not stated or characterized as multiple) were
excluded.
Data analysis
We used the chi-square test to assess the association
between adherence to the recommendation of submitting
4 specimens and the proportion of patients with patho-
logical findings consistent with CD. Because this dataset
did not contain information on serological findings or
follow-up clinical information, we defined a priori hav-
ing a result of either blunted villi (Marsh IIIA) or flat villi
(Marsh IIIB/C) as meeting the pathological definition of
CD. For assessing the relationship between ordinal cat-
egories such as year or number of specimens and the
pathologic diagnosis of CD, we used the Cochran-
Armitage test for trend.
Given the possibility that gross endoscopic findings
may be associated with both the number of specimens
submitted and the probability of CD, we investigated the
relationship between adherence to submitting 4 speci-
mens and CD while stratifying by gross endoscopic find-
ings. We used the Breslow-Day test for homogeneity of
odds ratios (OR) so as to assess whether gross appearance
modifies this association.
Generalized estimating equation multivariate logistic
regression was used to determine factors associated with
the submission of 4 specimens, adjusted for clustering
by individual provider. We postulated that adherence to
this practice was correlated with individual providers. Us-
ing the generalized estimating equation in this multivariate
analysis takes such clustering into account when the vari-
ance of hypothesized associations is estimated.
We used SAS version 9.1 (Cary, NC) for all statistical
calculations. All P values presented are 2-sided. The Insti-
tutional Review Board of Columbia University Medical
Center evaluated this study protocol and designated it as
“non-human subject research” involving de-identified
records.
RESULTS
A total of 150,155 procedures involving a duodenal/
small-bowel biopsy were submitted for histopathologic
evaluation during the 4-year period. Of these 150,155
procedures, 17,803 patients met at least one of the exclu-
sion criteria: known CD at the start of the procedure (n 
1841), repeated procedures (n  9531), and biopsies in
which the number of specimens was not noted (n 7871).
he remaining sample size for the analysis was 132,352.
Characteristics of the 132,352 patients included in the
nalysis are enumerated in Table 1. It can be seen that 67%
f the patients were women, and the mean ( standard
eviation [SD]) age was 52.9  16.7 years. Gross abnor- (
www.giejournal.org Valities such as scalloping and decreased folds accounted
or less than 2% of all gross descriptions.
Marsh I or II lesions were noted in 5944 individuals
TABLE 1. Characteristics of patients undergoing
duodenal biopsy, not known to have celiac disease
(n 132,352)
Characteristic No. of patients (%)
Sex*
Male 44,256 (33.5)
Female 88,016 (66.5)
Age, mean ( SD), y 52.9 ( 16.7)
Year of procedure
2006 20,209 (15.3)
2007 27,224 (20.6)
2008 38,765 (29.3)
2009 46,154 (34.5)
Pathologic finding*
Normal/unremarkable 104,682 (79.1)
Duodenitis 11,732 (8.9)
Mild intraepithelial
lymphocytosis
657 (0.5)
Intraepithelial lymphocytosis 5944 (4.5)
Blunted villi 819 (0.6)
Flat villi 628 (0.5)
Indication*
Anemia 25,628 (19.4)
Diarrhea 22,689 (17)
Dyspepsia 17,854 (13.5)
Heartburn 24,714 (18.7)
Weight loss 10,464 (7.9)
Suspected celiac disease/
malabsorption
10,808 (8.2)
Gross finding*
Normal 21,804 (16.5)
Abnormal 8411 (6.4)
Duodenitis 5936 (4.5)
Scalloping 527 (0.4)
Decreased folds 16 (0.01)
Erythematous 2229 (1.7)
*Sum does not equal total sample size because of missing data
points.4.5%), whereas Marsh IIIA was found in 819 (0.6%), and
olume 74, No. 1 : 2011 GASTROINTESTINAL ENDOSCOPY 105
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Adherence to guidelines and celiac disease diagnosis Lebwohl et alMarsh IIIB/C was found in 628 (0.5%). When a patholog-
ical diagnosis of CD was defined as blunted or flat villi
(Marsh IIIA/B/C), a total of 1447 individuals (1.1%) were
categorized as having CD.
The most common number of small-bowel specimens
submitted during upper endoscopy was 2 (histogram; Fig.
1). The mean ( SD) number of specimens submitted was
3.1 1.6, and the median number submitted was 3. Of the
132,352 patients undergoing upper endoscopy with small-
bowel biopsy, 4 small-bowel specimens were submitted
n 45,995 patients (35%). The proportion of patients with
4 specimens submitted during endoscopy increased
rom 33.8% in 2006 to 37.2% in 2009 (P for trend  .0001).
Of the 45,995 individuals with4 specimens submitted,
pathologic diagnosis of CD was present in 824 (1.8%),
hereas among the 86,357 patients in whom 4 speci-
ens were submitted, CD was present in 623 (0.7%; P 
0001). When treated as a continuous variable, the number
f specimens submitted was directly correlated with the
robability of a pathologic diagnosis of CD (Fig. 2). Biopsy
f the duodenal bulb was performed in 10% of patients;
nclusion of a bulbar biopsy was not associated with an
ncreased proportion of adherence to 4 small-bowel
pecimens (P  .4309), nor was it associated with an
ncreased probability of a pathological diagnosis of CD
OR 0.93; 95% confidence interval [CI], 0.78-1.11; P 
4373).
Patients with abnormal gross duodenal findings on en-
oscopy had an increased prevalence of CD (3.2% vs
.7%; OR 4.64; 95% CI, 3.80-5.67). The relationship be-
ween adherence to the standard of 4 specimens sub-
itted and a pathologic diagnosis of CD stratified by gross
ndoscopic findings is presented in Table 2. Gross endo-
copic findings modified the association between number
f specimens submitted and the prevalence of CD
Breslow-Day test for homogeneity of ORs: P  .0015).
Figure 1. Histogram of number of specimens of small-bowel biopsies
among individuals not known to have celiac disease undergoing upper
GI endoscopy with duodenal biopsy (n  132,352).his relationship was greater for those with abnormal 1
106 GASTROINTESTINAL ENDOSCOPY Volume 74, No. 1 : 2011ross findings (OR 3.67; 95% CI, 2.86-4.72) than for those
ith normal gross findings (OR 1.91; 95% CI, 1.38-2.63).
Among physicians who submitted duodenal biopsy
pecimens to this laboratory from at least 10 upper endos-
opies during the study period (n  1243), the adherence
ate to the proposed standard varied widely (mean adher-
nce rate 38%, SD 27.8%). There was an adherence rate of
etween 0% and 10% for 19% of providers.
Adherence varied by indication (Table 3), with highest
ates among examinations performed for evaluation of
iarrhea (43.9%) and lowest levels of adherence among
rocedures in which the indication was heartburn/GERD
30.0%). Among the different indications, the diagnostic
ield of submitting 4 specimens was variable (Table 3)
ut remained significantly associated with increased odds
f diagnosing CD for every indication. Of note, among
atients whose only indication was malabsorption or sus-
ected CD (n  3261), adherence to this quality standard
ccurred in 38.5% of examinations.
The results of generalized estimating equation multivar-
ate analysis of factors associated with the submission of
4 specimens during upper endoscopy while adjusting
or clustering by individual provider are shown in Table 4.
atient age was associated with decreased odds of adher-
nce, with individuals over 80 having the lowest odds of
dherence compared with those younger than 30 (OR
.67; 95% CI, 0.57-0.78). Clinical indication for endoscopy
as significantly associated with the number of specimens
ubmitted, with increased adherence to submitting 4
pecimens for individuals with diarrhea (OR 1.20; 95% CI,
.10-1.30) and malabsorption (OR 1.42; 95% CI, 1.10-1.85)
nd decreased adherence for patients undergoing endos-
opy for dyspepsia (OR 0.78; 95% CI, 0.72-0.86) and heart-
urn (OR 0.78; 95% CI, 0.70-0.87). Abnormal gross find-
ngs were associated with decreased odds of submitting
4 specimens (OR 0.75; 95% CI, 0.69-0.81). The modest
emporal trend of increased adherence to submitting 4
pecimens remained significant in this multivariate analy-
is (OR for 2009 compared with 2006: 1.51; 95% CI,
igure 2. Number of specimens submitted and the probability of the
iagnosis of celiac disease (Marsh IIIA/B/C, P for trend  .0001)..22-1.88).
www.giejournal.org
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Lebwohl et al Adherence to guidelines and celiac disease diagnosisDISCUSSION
In this analysis of a national pathology database of duo-
denal biopsies, 35% of patients had4 specimens submitted
during upper endoscopy. Adherence to this proposed stan-
dard1,13 remained low even among those patients with
alabsorption/suspected CD, with fewer than 40% of such
atients having4 specimens submitted. Regardless of indi-
ation, adherence to this proposed quality standard was
TABLE 2. Association of number of specimens submitted with t
Outcome <4 specimens (%)
All patients (n 132,352) 86,357 (65.2)
Normal gross appearance
(n 21,804)
12,866 (59)
Intraepithelial lymphocytosis 579 (4.43)
Blunted villi 45 (0.35)
Flat villi 21 (0.16)
Marsh IIIA/B/C 66 (0.51)
Abnormal gross appearance
(n 8411)
5755 (68.4)
Intraepithelial lymphocytosis 181 (3.15)
Blunted villi 61 (1.06)
Flat villi 41 (0.71)
Marsh IIIA/B/C 102 (1.77)
OR, Odds ratio; CI, confidence interval; –, not applicable.
*Breslow-Day test for homogeneity of ORs: chi-square 10.0245, df 1; P .00
TABLE 3. Submission of>4 versus<4 specimens
according to indication and OR of a diagnosis of CD
when>4 specimens are submitted
Indication
No. (%) with>4
specimens
submitted
OR for
diagnosis of CD
when>4
specimens
submitted
Anemia 9695 (37.8) 2.65 (2.13-3.30)
Diarrhea 9489 (43.9) 1.86 (1.46-2.37)
Dyspepsia 4627 (33.0) 2.94 (1.94-4.43)
Heartburn 4923 (30.0) 1.84 (1.33-2.55)
Weight loss 2091 (38.8) 1.83 (1.08-3.11)
Suspected celiac
disease/
malabsorption
1256 (38.5) 7.37 (4.70-11.57)
OR, Odds ratio; CD, celiac disease.ssociated with an increased rate of CD diagnosis. i
www.giejournal.org VThis study evaluated the recommended practice of sub-
itting 4 specimens when a diagnosis of CD is under
onsideration.1,13 This proposed guideline is new and sub-
ect to debate. As one recent review stated, “the optimal
ethod of obtaining biopsies in patients with celiac dis-
ase is controversial.”20 This proposed guideline has not
een established prospectively, and this recommendation
temmed instead from the observation that the histopatho-
ogic abnormalities of CD are patchy and can be missed
ntirely if an insufficient quantity of specimens is submit-
ed. The recommendation was subsequently supported by
single-center retrospective study of 93 patients with CD,
hich found that 4 specimens led to a positive diagnosis in
00% of patients, whereas 2 specimens were diagnostic in
nly 90% of patients.14 Those authors concluded that at
east 4 duodenal biopsy specimens should be taken to rule
ut CD. A second study, investigating 56 patients with
nown CD,15 found that 3 biopsy specimens were suffi-
ient as long as 1 specimen was obtained from the duo-
enal bulb; however, 5 biopsy specimens were necessary
o recognize the most severe extent of villous atrophy.
hese studies are limited by their small sample size and
ingle-center settings.
To our knowledge, no previous study has evaluated the
iagnostic yield of submitting 4 specimens for patients
ithout known CD in accordance with these proposed
uidelines. The incremental yield of submitting 4 spec-
mens has not been evaluated in a population undergoing
ndoscopy for a variety of indications, in which only a
mall proportion of patients will have celiac disease, and
agnosis of celiac disease, stratified by gross appearance
>4 specimens (%) OR (95% CI) P value
45,995 (34.8) – –
8938 (41)
484 (5.42) 1.24 (1.09-1.40) .0009
57 (0.64) 1.83 (1.24-2.71) .0022
30 (0.34) 2.06 (1.18-3.60) .0095
87 (0.97) 1.91 (1.38-2.63)* .0001
2656 (31.6) –
128 (4.82) 1.56 (1.24-1.96) .0001
82 (3.09) 2.97 (2.13-4.16) .0001
83 (3.13) 4.50 (3.08-6.55) .0001
165 (6.21) 3.67 (2.86-4.72)* .0001he din which such patients may have a more patchy distribu-
olume 74, No. 1 : 2011 GASTROINTESTINAL ENDOSCOPY 107
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Adherence to guidelines and celiac disease diagnosis Lebwohl et altion of pathologic abnormalities. Moreover, adherence
was low even for those who consider 3 specimens to be
satisfactory,20 because the most common submitted num-
er of specimens was 2 (Fig. 1).
These results indicate that this proposed standard ap-
ears to be slowly diffusing into clinical practice, because
he proportion of individuals undergoing duodenal biopsy
ho have4 specimens submitted increased between the
ears 2006 and 2009. Nevertheless, this practice was per-
TABLE 4. Generalized estimating equationmultivariate
analysis of factors associated with submission of>4
specimens, adjusting for clustering by individual
provider
Characteristic OR 95% CI P value
Age, y  .0001
30 1.0 – –
30-39 1.08 0.79-1.48 .6208
40-49 0.96 0.85-1.09 .5572
50-59 0.94 0.84-1.05 .2881
60-69 0.85 0.76-0.96 .0062
70-79 0.82 0.73-0.92 .0011
80 0.67 0.57-0.78 .0001
Sex
Male 1.0 – –
Female 1.05 0.99-1.12 .1207
Indication .0001
Anemia 1.0 – –
Diarrhea 1.20 1.10-1.30 .0001
Dyspepsia 0.78 0.72-0.86 .0001
Heartburn 0.78 0.70-0.87 .0001
Weight loss 1.04 0.91-1.19 .5674
Suspected celiac
disease/malabsorption
1.42 1.10-1.85 .008
Gross finding
Normal 1.0 – –
Abnormal 0.75 0.69-0.81 .0001
Year .0095
2006 1.0 – –
2007 1.28 1.03-1.60 .0288
2008 1.38 1.11-1.72 .0035
2009 1.51 1.22-1.88 .0002
OR, Odds ratio; CI, confidence interval; –, not applicable.ormed in a minority of patients even in 2009, when only r
108 GASTROINTESTINAL ENDOSCOPY Volume 74, No. 1 : 20117% of patients had 4 specimens submitted. Guidelines
re adopted by physicians at variable rates, and at times
his variability creates new racial or socioeconomic dispar-
ties.21 In our study, we did not have access to socioeco-
omic or racial data to determine whether these individual
atient characteristics were associated with the submission
f the recommended number of specimens.
In this study, the incremental diagnostic yield of submit-
ing 4 specimens was large, because the proportion of
atients diagnosed with CD was doubled when 4 speci-
ens were submitted. This incremental yield varied by indi-
ation and was greatest when the indication was
alabsorption/suspected CD (OR 7.37; 95% CI, 4.70-11.57)
r anemia (OR 2.65; 95% CI, 2.13-3.30). However, submitting
4 specimens also increased the diagnostic yield of CD even
hen the indication was GERD (OR 1.84; 95% CI, 1.33-2.55).
e therefore conclude that, although the increased diagnos-
ic yield of adherence varies in magnitude, it is present and
hould be adhered to regardless of indication.
Why were 4 specimens submitted only 35% of the
ime? One possibility is that this proposed guideline is new
nd not fully accepted.1,13,20 Another possibility is that
nowledge of the appropriate amount of specimens to
ubmit is not yet widespread. This explanation is sup-
orted by the finding that the submission of4 specimens
as modestly increased over time (OR for 2009 vs 2006,
.58; 95% CI, 1.27-1.97). A third contributing factor is the
xtra time involved in submitting additional specimens.
he most common number of specimens submitted in this
ataset was 2 (Fig. 1). Two specimens usually can be
ollected by using one pass of the biopsy forceps. A
econd pass of the forceps, done for the purpose of col-
ecting additional specimens, increases the length of the
rocedure. Although the amount of time for an additional
ass of the biopsy forceps for additional biopsies is low
approximately 1 minute), the incremental yield of this
dditional time taken was heretofore unknown. Given the
igh incremental yield in the present analysis (resulting in
doubling of the proportion of patients with a patholog-
cal diagnosis of CD), the proposed standard of submitting
4 specimens appears to be justified.
We observed a marked variability between individual
ndoscopists with regard to the proportion of examina-
ions in which the recommended number of specimens
as submitted. Although the mean adherence rate among
roviders was 38.3%, the most common percentage ad-
erence per individual was between 0% and 10%. The
ide variability in adherence to this recommendation is
eminiscent of the variability of a familiar quality indicator
n gastroenterology, the adenoma detection rate in screen-
ng colonoscopy.22 The discovery of that variability and
ssociated predictive factors such as colonoscope with-
rawal time23 has led to a focus on high-quality colonos-
opy as a priority for the profession of gastroenterology.24
he findings in the present study, of low adherence to a
ecommendation in the face of a high diagnostic yield of
www.giejournal.org
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Lebwohl et al Adherence to guidelines and celiac disease diagnosissubmitting 4 specimens, should spur efforts to increase
adherence to this standard.
This study has several limitations. This was a retrospec-
tive analysis of a pathology tissue database, which has
nevertheless yielded high-quality analyses of GI epidemi-
ology and quality measures.25-26 In this database, we did
not have access in all patients to key variables that influ-
ence the likelihood of CD, such as data regarding family
history of CD or serology results. Those with positive CD
serology results (ie, noted in the clinical indication field)
were classified in the “suspected CD” indication category;
this variable was included in the multivariate analysis.
Information regarding the type of sedation used during the
procedure and degree of sedation, which may have im-
pacted the ability to obtain 4 specimens, was not avail-
able. The diagnosis of CD in this study was based strictly
on histopathologic findings, and reliance on histology
alone has been criticized for its lack of specificity.27 For
this reason, we considered only the most severe histo-
pathologic changes (Marsh III lesions) as CD, excluding
the increasingly common report of increased intraepithe-
lial lymphocytosis, so as to maximize the specificity of the
outcome in this analysis.
Certain providers may have a particular interest or exper-
tise in CD and thus are more likely to submit 4 specimens.
We therefore performed the generalized estimating equation
multivariate analysis, adjusting for clustering by individual
provider. The fact that the association between the number
of specimens submitted and the diagnosis of CD is magnified
when those high pretest probability strata (such as gross
abnormal appearance or indication of suspected CD/
malabsorption) are examined supports the argument that the
relationship between submitting 4 specimens and an in-
reased probability of CD is causal and robust.
We conclude that4 specimens are submitted during the
rocedure only in the minority of individuals undergoing
pper GI endoscopy with duodenal biopsy in the United
tates. Even among those patients with an indication for
ndoscopy of malabsorption or suspected CD (including
ositive serology results), adherence to this proposed stan-
ard occurred in only 38.5% of examinations. The additional
iagnostic yield of submitting 4 specimens varies by indi-
ation and gross appearance but is in all cases associated
ith an increased probability of a diagnosis of CD. Given the
igh incremental yield of submitting4 specimens, efforts to
ncrease adherence to this standard are warranted.
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